Protective HA Factors
Protective HA Factors
This is a naturalistic study of 100 migraineurs and 75 post concussive headache patients who
 will be asked to record their headaches, medications, sleep and other behaviors in a
 smartphone app called Curelator. The software was developed to identify possible headache
 triggers. We seek to determine whether there might be protective headache factors. Patients
 will be given audio files with relaxation therapies. We seek to understand whether this self
 relaxation therapy and/or traditional evidence based behavioral treatment recommended during
 a patient visit is protective against migraine attacks.
Patients will be given a link to audio files on dropbox which they can download onto their
 smartphone. They consist of breathing techniques, imaging, progressive relaxation, and more.
 Patients will be asked to perform 20 minutes of relaxation therapy at least 3 times a week.
 Patients will record their headache frequency and intensity, in addition to other symptoms,
 and the frequency of practicing the behavioral therapy using Curelator Headache. ™ Curelator
 Inc. (Cambridge USA) has developed a proprietary, non-pharmaceutical, digital platform,
 called Curelator Headache,™ to collect daily data, identify trigger-attack associations and
 propose 'tests' of trigger modification.

 The Curelator approach requires high quality data from the individual, entered on a daily
 basis. Compliance is expected to be enhanced because the study if being offered by the
 individual's healthcare provider.

 This a pilot study of an initial 90 days use of a digital platform to identify potential
 migraine protective factors (Curelator Headache™) in subjects with physician-diagnosed
 episodic or chronic migraine or post-concussive headache. Subjects are recruited to Curelator
 Headache use by a physician and enter data each day. The baseline period (90 days) is
 followed by a test period (90 days) during which, under Curelator guidance, subjects make one
 or more modifications to their behaviors based on the data from the 90 day period.

 The study will include up to 100 patients with chronic or episodic migraine and 75 patients
 with postconcussive headache. At clinics, investigators will offer participation to
 consecutive migraine patients with 6-20 headache days a month and to consecutive concussion
 patients complaining of headache more than 1 month post concussive event.
Inclusion Criteria:

 -  Male or female reporting at least 6 month history of episodic or chronic migraine with
 6-20 headache days a month

 -  Age: 18-65 years

 -  Age of onset of migraine was <age 50

 -  Able to give informed consent/assent

 -  Sufficiently fluent in English to be able to use the English language version of
 Curelator Headache (no translations available).

 -  Has ownership of or reliable access to iPhone or (mini) iPad running iOS 7 or higher

 -  Able to give written informed consent (adults), or, for adolescents, has a
 parent/caregiver who can give informed consent and adolescent is able to give assent.

 -  Willing to use Curelator Headache for at least 3 months and to comply with study
 procedures.

 -  In the Investigator's opinion, there is no reason to believe that Curelator Headache
 use would pose any risk to the patient.

 Exclusion Criteria: